<DOC>
	<DOCNO>NCT02414594</DOCNO>
	<brief_summary>The purpose ass safety , tolerability , pharmacokinetics , pharmacodynamics IONIS APO ( ) -LRx ( ISIS 681257 ) give healthy volunteer subject .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics , Pharmacodynamics IONIS APO ( ) -LRx Healthy Volunteers With Elevated Lipoprotein ( )</brief_title>
	<detailed_description />
	<criteria>Must give write informed consent able comply study requirement Healthy male female age 1865 inclusive weigh ≥ 50 kg time inform consent Females must nonpregnant nonlactating , either surgically sterile post menopausal Males must surgically sterile , abstinent use acceptable contraceptive method BMI &lt; 35.0 kg/m2 Subjects must Lp ( ) ≥ 75 nanomoles/liter nmol/L ( 30 mg/dL ) Screening Known history positive test human immunodeficiency virus ( HIV ) , hepatitis C chronic hepatitis B Treatment another Study Drug , biological agent , device within onemonth screen Regular use alcohol within 6 month Screening Use concomitant drug unless authorize Sponsor Medical Monitor Smoking &gt; 10 cigarette day Considered unsuitable inclusion Principal Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>